Interview: A perspective on personalized medicine: Dr David Korn

Personalized Medicine
David Korn

Abstract

David Korn speaks to Tarryn Greenberg, Managing Commissioning Editor David Korn (BA, scl, MD, cl; Harvard University, MA, USA) stepped down from his position as Harvard University's inaugural Vice-Provost for Research on June 30, 2011. He is presently Consultant in Pathology and member of the medical staff at the Massachusetts General Hospital, Boston, MA, USA and Professor of Pathology at Harvard Medical School. Dr Korn has been a member of the editorial boards of the American Journal of Pathology, The Journal of Biological Chemistry, and Human Pathology, and for many years was an Associate Editor of the latter. He has sat on many societies, councils and boards. He has written many scientific articles, ranging from bacteriophage biochemistry and genetics to the biochemistry and molecular biology of DNA replication in human cells. During the past two decades his work, writings and lectures have focused on issues of academic values and integrity, research integrity, and health and science policy, and he is presently regarded as a national authority on matters of financial conflicts of interest in academic research.

Citations

May 1, 2013·Personalized Medicine·Julius Alexander Steffen, Christian Lenz
Jan 1, 2013·Journal of Personalized Medicine·Julius Alexander Steffen, Jan Simon Steffen

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bacteriophage: Phage Therapy

Phage therapy uses bacterial viruses (bacteriophages) to treat bacterial infections and is widely being recognized as an alternative to antibiotics. Here is the latest research.